secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001638833-22-000017
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q4 2021 Adj. EBITDA $114.4M, raises 2022 guidance
------------------------------------------------------------------

- Q4 2021 revenue $610.2M (+11.3% YoY); net loss $0.1M; Adj. EBITDA $114.4M (+26.0%, incl. $11.6M CARES grants).
- Full-year 2021 revenue $2.225B (+19.6% YoY); Adj. EBITDA $339.6M (+32.3%, incl. $25.3M CARES grants).
- Days adjusted same-facility revenue +9.6% in Q4; case volume +4.2%. Full-year same-facility revenue +18.1%.
- 2022 guidance: revenue at least $2.5B (+12% YoY); Adj. EBITDA $370-380M, raised from prior outlook.
- Cash $389.9M at Dec. 31; total net debt/EBITDA leverage 5.58x; capital deployment target at least $200M annually.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000017/0001638833-22-000017-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883322000017/sgry-20220228.htm
  HTML page:      https://secwatch.observer/filing/0001638833-22-000017

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer